Apr 20 – Page 3 – CancerObesityConnection.org

A very good day for Lilly, and a bad day for Novo

April 20, 2025April 18, 2025 by Condie Carmack

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today we talk about Eli Lilly’s stock jumping after it released new data on its GLP-1 pill, see Sanofi partner with a mysterious company, and more. Read the rest…

GLP-1 pill: Eli Lilly says its oral orforglipron showing “promising results” – Axios

April 20, 2025April 18, 2025 by Condie Carmack

GLP-1 pill: Eli Lilly says its oral orforglipron showing “promising results” Axios Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar The New York Times A very good day for Lilly, and a bad day for Novo statnews.com Lilly’s oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with … Read more